(Q95781752)
Statements
Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir (English)
Weerawat Manosuthi
Somnuek Sungkanuparph
Wisit Prasithsirikul
Chatiya Athichathanabadi
Woraphot Tantisiriwat
Chureeratana Bowonwatanuwong
Nopphanath Chumpathat